Thermo Fisher Scientific Inc. has authorized a quarterly cash dividend of $0.47 per common share, providing income returns to shareholders. The dividend is payable on October 15, 2026, to shareholders of record as of September 15, 2026. The company's Board of Directors approved the payout, reinforcing its commitment to returning capital to investors.

Dividend Details

The payment schedule for the declared dividend is outlined below:

Company Overview

Thermo Fisher Scientific Inc. serves as the world leader in serving science, with annual revenue over $45 billion. The company's mission is to enable customers to make the world healthier, cleaner, and safer. Its global team delivers innovative technologies, purchasing convenience, and pharmaceutical services through industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

Thermo Fisher Scientific announced that its Applied Biosystems RapidINTEL Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. This regulatory milestone allows the company's Rapid DNA workflow on the RapidHIT ID System to become the first eligible to generate DNA profiles that can be searched against the national CODIS database network when FBI requirements are met. The approval significantly accelerates access to investigative DNA intelligence, reducing the time required from days or weeks to just hours.

The FBI's NDIS approval validates the technical capabilities of the RapidINTEL Plus Cartridge within the RapidHIT ID System for forensic applications. By meeting the stringent requirements set by the FBI, the system enables law enforcement agencies to process crime scene samples more efficiently. The ability to rapidly generate and search DNA profiles against the CODIS database enhances the speed and accuracy of criminal investigations.

The Rapid DNA workflow facilitated by the RapidHIT ID System is designed to streamline the DNA profiling process. The inclusion of the RapidINTEL Plus Cartridge in the NDIS approval expands the scope of samples that can be processed rapidly. This development is expected to support law enforcement agencies in time-sensitive investigations where quick DNA analysis is critical.

Key Features of the Approved System

The approval marks a significant advancement in forensic technology, providing law enforcement with a powerful tool for rapid DNA analysis. Thermo Fisher Scientific continues to innovate in the field of forensic science, delivering solutions that enhance the capabilities of investigative agencies.